Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects

Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia. To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI. 96 MCI participants were f...

Full description

Saved in:
Bibliographic Details
Published inJournal of Alzheimer's disease Vol. 70; no. 1; p. 25
Main Authors Dietlin, Simon, Soto, Maria, Kiyasova, Vera, Pueyo, Maria, de Mauleon, Adelaïde, Delrieu, Julien, Ousset, Pierre Jean, Vellas, Bruno
Format Journal Article
LanguageEnglish
Published Netherlands 01.01.2019
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia. To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI. 96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study. The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders. Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD.
AbstractList Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia. To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI. 96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study. The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders. Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD.
Author Soto, Maria
Ousset, Pierre Jean
de Mauleon, Adelaïde
Kiyasova, Vera
Dietlin, Simon
Pueyo, Maria
Delrieu, Julien
Vellas, Bruno
Author_xml – sequence: 1
  givenname: Simon
  surname: Dietlin
  fullname: Dietlin, Simon
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
– sequence: 2
  givenname: Maria
  surname: Soto
  fullname: Soto, Maria
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
– sequence: 3
  givenname: Vera
  surname: Kiyasova
  fullname: Kiyasova, Vera
  organization: Institut de Recherches Internationales Servier, Suresnes, France
– sequence: 4
  givenname: Maria
  surname: Pueyo
  fullname: Pueyo, Maria
  organization: Institut de Recherches Internationales Servier, Suresnes, France
– sequence: 5
  givenname: Adelaïde
  surname: de Mauleon
  fullname: de Mauleon, Adelaïde
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
– sequence: 6
  givenname: Julien
  surname: Delrieu
  fullname: Delrieu, Julien
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
– sequence: 7
  givenname: Pierre Jean
  surname: Ousset
  fullname: Ousset, Pierre Jean
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
– sequence: 8
  givenname: Bruno
  surname: Vellas
  fullname: Vellas, Bruno
  organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31127783$$D View this record in MEDLINE/PubMed
BookMark eNo1jztPwzAYAC0Eog9Y-AHIG1PAsZs4GaOWR1F5iMJcOfbn1qW2g-0ihV8PEjDddroboUPnHSB0lpNLRhm7um9mWV4TQosDNMwrXmRVTaoBGsW4JYQwUvNjNGB5Tjmv2BB9PMI--C72cmNECkbiZW-75G3Ewin8YuI79ho_B78OEKPxDiePm93XBoyFcBHxzEQQEXBjvVvjB7NTeOrXziTzCXhuO2GCBZfwct9uQaZ4go602EU4_eMYvd1cv07vssXT7XzaLDLJqjxlgnJQZfHTWwPTUEzaqtZcc9ZKVmrJJKsl1bqsFSg5KUjZkpICVWWrJCit6Rid_3q7fWtBrbpgrAj96v-dfgPsdl2T
CitedBy_id crossref_primary_10_1038_s41398_024_02968_y
crossref_primary_10_1177_08919887221093361
crossref_primary_10_1186_s13195_023_01255_0
crossref_primary_10_1590_1980_5764_dn_2020_0096
crossref_primary_10_1186_s12877_024_05203_x
crossref_primary_10_1016_j_jagp_2021_12_014
crossref_primary_10_1016_j_neuint_2021_105250
crossref_primary_10_1186_s12877_023_04447_3
crossref_primary_10_1186_s12877_023_04580_z
crossref_primary_10_3233_JAD_190828
crossref_primary_10_1590_1980_5764_dn_2024_0187
crossref_primary_10_1038_s44220_023_00191_0
crossref_primary_10_1097_WAD_0000000000000480
crossref_primary_10_2147_NDT_S454943
crossref_primary_10_3233_JAD_200604
crossref_primary_10_3233_JAD_230170
crossref_primary_10_1038_s41380_022_01459_0
crossref_primary_10_3233_JAD_220857
crossref_primary_10_1038_s41582_021_00597_3
crossref_primary_10_1111_jnc_15715
crossref_primary_10_3389_fnagi_2021_718949
crossref_primary_10_3233_JAD_215555
crossref_primary_10_1159_000507078
crossref_primary_10_1186_s13195_020_00604_7
crossref_primary_10_2174_1567205019666220805114528
crossref_primary_10_1177_17474930211006294
crossref_primary_10_1186_s13195_024_01386_y
crossref_primary_10_1016_j_nbas_2022_100044
crossref_primary_10_1111_psyg_12697
crossref_primary_10_1007_s13311_022_01185_z
crossref_primary_10_1002_alz_12519
crossref_primary_10_3233_JAD_240556
crossref_primary_10_1080_13854046_2023_2273574
crossref_primary_10_1038_s44220_023_00043_x
crossref_primary_10_1016_j_jagp_2024_06_005
crossref_primary_10_3389_fneur_2024_1422681
crossref_primary_10_1002_dad2_12164
crossref_primary_10_2174_1871527322666230301111216
crossref_primary_10_1124_pharmrev_124_001117
crossref_primary_10_3233_JAD_210037
crossref_primary_10_1177_08919887221093353
crossref_primary_10_1186_s13195_024_01526_4
crossref_primary_10_1007_s11065_023_09608_0
ContentType Journal Article
DBID NPM
DOI 10.3233/JAD-190025
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1875-8908
ExternalDocumentID 31127783
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
0VX
29J
36B
4.4
53G
5GY
AAFNC
AAWTL
ABDBF
ABIVO
ABJNI
ABUBZ
ABUJY
ACGFS
ACPQW
ACPRK
ACUHS
ADZMO
AELRD
AENEX
AFRAH
AFRHK
AGIAB
AHDMH
AIRSE
AJNRN
ALMA_UNASSIGNED_HOLDINGS
CAG
COF
DU5
EAD
EAP
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
HZ~
IL9
IOS
MET
MIO
MV1
NGNOM
NPM
O9-
P2P
Q1R
S70
SV3
TUS
VUG
ID FETCH-LOGICAL-c381t-a27ed650979e3fe54b89f7f73bc36fc3c39c2ff69dedc4506b062e2d6bdcedff2
IngestDate Thu Apr 03 07:05:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords dementia
mild cognitive impairment
Alzheimer’s disease
neuropsychiatric symptoms
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-a27ed650979e3fe54b89f7f73bc36fc3c39c2ff69dedc4506b062e2d6bdcedff2
PMID 31127783
ParticipantIDs pubmed_primary_31127783
PublicationCentury 2000
PublicationDate 2019-01-01
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of Alzheimer's disease
PublicationTitleAlternate J Alzheimers Dis
PublicationYear 2019
SSID ssj0003097
Score 2.438837
Snippet Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia. To...
SourceID pubmed
SourceType Index Database
StartPage 25
Title Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/31127783
Volume 70
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELbKJiFe0KYNGGyTHybxgDzSOInrx2oMMSYmRGHiDcXOWUSiTUdTpPbv2B-8s52kbQTT2EsU2UkU5ftyvjvfD0I-acBVN1IhiyAQLEp5l6lunLFAK7SIeGJSlx599iM5uYpOr-PrTuf3UtTStFSf9fzRvJL_QRXHEFebJfsMZJuH4gCeI754RITx-E8Yu8oaTbxyrg8Gs-G4LIa-7vJFFTV-bkOwfPkNq2n27-a3kLumKWJiq2_aDZqDvms6dJbfZSgi6oiibygr8nsXLoACxnpsJk8psysPbe36HOVQVn3hB_lwse8_KFwPJ5svlDerw_d8lk6KB6fT_oT7Zvx8CrPW1ZWzwuZHNc4K8AIW7SPWk0FvWQL71iErTKvEafyYlOeh9UIfn_aPGKozwepFiNB46PDmqEoK4dvk_H22VXG7nloja2h72Gaq1gNUre48kMKXubWvcbh4iQ2yXt_YMlGcqnL5imxWsNC-J8xr0oHRG_KrTRZak4UiWaglCy0MXSILLQva4Lo_oRVVqKMKtVShDVXogiq0pspbcnX89fLLCav6bTCNelvJ0lBAZisqCgncQBypnjTCCK40_rSaay51aEwiM8h0FAeJCpIQwixRmYbMmHCLvBgVI9gh1NjGj4FC256jxZ5yaWQsQaC0VyrSSfcd2fZf6Gbsi6rc1N9u98mZPbKxoNR78tLgXwwfUCUs1UeH0R_l_2Xy
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuropsychiatric+Symptoms+and+Risk+of+Progression+to+Alzheimer%27s+Disease+Among+Mild+Cognitive+Impairment+Subjects&rft.jtitle=Journal+of+Alzheimer%27s+disease&rft.au=Dietlin%2C+Simon&rft.au=Soto%2C+Maria&rft.au=Kiyasova%2C+Vera&rft.au=Pueyo%2C+Maria&rft.date=2019-01-01&rft.eissn=1875-8908&rft.volume=70&rft.issue=1&rft.spage=25&rft_id=info:doi/10.3233%2FJAD-190025&rft_id=info%3Apmid%2F31127783&rft_id=info%3Apmid%2F31127783&rft.externalDocID=31127783